Specific Transduction of HIV-Susceptible Cells for CCR5 Knockdown and Resistance to HIV Infection: A Novel Method for Targeted Gene Therapy and Intracellular Immunization

Journal of Acquired Immune Deficiency Syndromes - United States
doi 10.1097/qai.0b013e3181b010a0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Gene Therapy for HIV-1 Infection

2011English

Targeting CCR5 Trafficking to Inhibit HIV-1 Infection

Science advances
Multidisciplinary
2019English

Naive Precursors of Human Regulatory T Cells Require FoxP3 for Suppression and Are Susceptible to HIV Infection

Journal of Immunology
AllergyImmunology
2008English

Development of HIV Vectors for Anti-Hiv Gene Therapy.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1996English

Natural Anti-Ccr5 Antibodies in HIV-infection and -Exposure

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2011English

HIV Treatment: Mechanisms of Neurotoxicity and Implications for Targeted Therapy

Neurobehavioral HIV Medicine
DermatologyPsychiatryMental HealthInfectious DiseasesBehavioral Neuroscience
2012English

V1 and V2 Domains of HIV Envelope Contribute to CCR5 Antagonist Resistance

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2019English

HIV-1 Resistance to CCR5 Antagonists Associated With Highly Efficient Use of CCR5 and Altered Tropism on Primary CD4+ T Cells

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2010English

Thymic Plasmacytoid Dendritic Cells Are Susceptible to Productive HIV-1 Infection and Efficiently Transfer R5 HIV-1 to Thymocytes in Vitro

Retrovirology
VirologyInfectious Diseases
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy